Literature DB >> 34719237

Elastin-Like Polypeptide: VEGF-B Fusion Protein for Treatment of Preeclampsia.

Jamarius P Waller1, John Aaron Howell2, Hali Peterson3, Eric M George4,5, Gene L Bidwell1,2,5.   

Abstract

[Figure: see text].

Entities:  

Keywords:  blood pressure; drug development; inflammation; plasma; pregnancy

Mesh：

Substances：

Year:  2021        PMID： 34719237      PMCID： PMC8585700          DOI： 10.1161/HYPERTENSIONAHA.121.17713

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


  43 in total

1.  Polymer size affects biodistribution and placental accumulation of the drug delivery biopolymer elastin-like polypeptide in a rodent pregnancy model.

Authors:  Marija Kuna; Jamarius P Waller; Omar C Logue; Gene L Bidwell
Journal:  Placenta       Date:  2018-10-20       Impact factor: 3.481

2.  Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of tumor necrosis factor-alpha.

Authors:  B Babbette D LaMarca; William A Bennett; Barbara T Alexander; Kathy Cockrell; Joey P Granger
Journal:  Hypertension       Date:  2005-09-06       Impact factor: 10.190

Review 3.  Pre-eclampsia and long-term health outcomes for mother and infant: an umbrella review.

Authors:  T Pittara; A Vyrides; D Lamnisos; K Giannakou
Journal:  BJOG       Date:  2021-03-23       Impact factor: 6.531

Review 4.  A model of preeclampsia in rats: the reduced uterine perfusion pressure (RUPP) model.

Authors:  Jing Li; Babbette LaMarca; Jane F Reckelhoff
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-04-20       Impact factor: 4.733

5.  Molecular hydrogen ameliorates several characteristics of preeclampsia in the Reduced Uterine Perfusion Pressure (RUPP) rat model.

Authors:  Takafumi Ushida; Tomomi Kotani; Hiroyuki Tsuda; Kenji Imai; Tomoko Nakano; Shima Hirako; Yumiko Ito; Hua Li; Yukio Mano; Jingwen Wang; Rika Miki; Eiko Yamamoto; Akira Iwase; Yasuko K Bando; Masaaki Hirayama; Kinji Ohno; Shinya Toyokuni; Fumitaka Kikkawa
Journal:  Free Radic Biol Med       Date:  2016-10-24       Impact factor: 7.376

6.  Application of thermally responsive polypeptides directed against c-Myc transcriptional function for cancer therapy.

Authors:  Gene L Bidwell; Drazen Raucher
Journal:  Mol Cancer Ther       Date:  2005-07       Impact factor: 6.261

7.  The soluble fms-like tyrosin kinase-1 (sFLT-1) to placental growth factor (PIGF) ratio as a possible indicator for the severity of preeclampsia - single institution experience.

Authors:  Andrijana Müller; Vesna Horvat; Martina Vulin; Sanja Mandić; Vatroslav Šerić; Domagoj Vidosavljević
Journal:  Med Glas (Zenica)       Date:  2019-02-01

8.  Pravastatin attenuates hypertension, oxidative stress, and angiogenic imbalance in rat model of placental ischemia-induced hypertension.

Authors:  Ashley J Bauer; Christopher T Banek; Karen Needham; Haley Gillham; Susan Capoccia; Jean F Regal; Jeffrey S Gilbert
Journal:  Hypertension       Date:  2013-03-04       Impact factor: 10.190

9.  A Maternally Sequestered, Biopolymer-Stabilized Vascular Endothelial Growth Factor (VEGF) Chimera for Treatment of Preeclampsia.

Authors:  Omar C Logue; Fakhri Mahdi; Heather Chapman; Eric M George; Gene L Bidwell
Journal:  J Am Heart Assoc       Date:  2017-12-08       Impact factor: 5.501

10.  Placental Growth Factor Reduces Blood Pressure in a Uteroplacental Ischemia Model of Preeclampsia in Nonhuman Primates.

Authors:  Angela Makris; Kristen R Yeung; Shirlene M Lim; Neroli Sunderland; Scott Heffernan; John F Thompson; Jim Iliopoulos; Murray C Killingsworth; Jim Yong; Bei Xu; Robert F Ogle; Ravi Thadhani; S Ananth Karumanchi; Annemarie Hennessy
Journal:  Hypertension       Date:  2016-04-18       Impact factor: 10.190
View more
  1 in total

Review 1.  Application of Elastin-like Polypeptide in Tumor Therapy.

Authors:  Xianggang Shi; Dongfeng Chen; Guodong Liu; Hailing Zhang; Xiaoyan Wang; Zhi Wu; Yan Wu; Feng Yu; Qinggang Xu
Journal:  Cancers (Basel)       Date:  2022-07-28       Impact factor: 6.575
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.